Clinical Trial Update: High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial assessing high-dose prophylactic gabapentin to prevent opioid use for oral mucositis pain during chemoradiation in head and neck cancer patients; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Squamous Cell Carcinoma
• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Gabapentin (Gabapentin)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Head and Neck Squamous Cell Carcinoma, Stage I Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8 | Phase 3 | Status: RECRUITING